Please see below to view details for this session presenter

Anand Mehra, MD

Partner, Sofinnova Ventures

Dr. Mehra joined Sofinnova Ventures in 2007 to focus on biopharmaceutical investing.  Currently, he is a director of Aerie Pharmaceuticals, Nextwave, and Marinus, and led the firm's investments in Vicept Therapeutics (Acquired:  Allergan).  Dr. Mehra also played an important role in the firm’s investments in Hyperion, Preglem (Acquired:  Gedeon Richter), and Amarin (NASDAQ:  AMRN).  Prior to joining Sofinnova Ventures, Dr. Mehra worked in JP Morgan’s private equity and venture capital group. Before joining the venture community, he was a consultant in McKinsey & Company's pharmaceutical practice, advising pharma and biotech on key strategic issues, and an NIH-funded Fellow focused on reperfusion injury in stroke.  Dr. Mehra received his M.D. from Columbia University’s College of Physicians and Surgeons; and graduated Phi Beta Kappa from the University of Virginia where he was an Echols Scholar and spent three years as a firefighter.